News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Adaptive Biotechnologies eyes expansion to Europe
Adaptive Biotechnologies announced that it is expanding operations to Europe following a big 2020, in which the biotech company signed 35 new lab partnerships in
Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
“I don’t think I’ve ever been as honoured and excited to be part of somebody’s mission as I am with Umoja.” Veteran investor Dr. Robert
Novo Nordisk makes headway in bid to rule obesity market with stunning phase 3 semaglutide data
Life Science Washington member Novo Nordisk has taken one step forward in its ambition to move its Type 2 diabetes drug semaglutide into the obesity
Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location
Canada-based Notch Therapeutics announced its plans to open a Seattle research laboratory as part of its U.S. expansion, following a recent Series A funding round
Startup Ozette unveils AI approach to understanding the immune system
Seattle-based startup Ozette raised $6 million in seed funding to propel its new AI-driven immune technology. While the company’s main focus is on accelerating analysis
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation
Nautilus Biotechnology, a Seattle-based startup, announced that it will go public via a special purpose acquisition (SPAC). Founded in 2016, Nautilus is building a combination